Publications

Journal Article Ahead of print
Open access — free full text available
Open access
Electronic publication date
November 12, 2026

View on Pubmed.gov 43017890 | View on doi.org 10.3928/1081597... | View the free full text Full text

Comparison of 1-Year Clinical Outcomes Following SmartSight Lenticule Extraction Among Three Different Astigmatism Groups.

Search for publications in this journal J Refract Surg

  • Hyosung Yoon

    Search for this expert
    Contact the corresponding author.
    Reported by OpenAlex: verify on the publication before relying on it.
    1
  • Thomas Magnago 2
  • Maren-Christina Lengle

    Search for this expert
    2
  • Samuel Arba-Mosquera 2
  • Donjg Ju Yeom

    Search for this expert
    1

Abstract

PURPOSE

To compare the clinical outcomes of three different cohorts for astigmatism after keratorefractive lenticule extraction using the ATOS femtosecond laser system (Smart-Sight; SCHWIND eye-tech-solutions).

METHODS

In this retrospective, observational, non-randomized cohort study, 216 eyes from 129 patients treated consecutively with SmartSight lenticule extraction were retrospectively analyzed in three groups based on three different levels of astigmatism (low: 0.00 to -1.00 diopters [D]; moderate: -1.01 to -2.99 D; high: -3.00 to -5.25 D). Over all three groups, the patients' mean age was 27 ± 5 years (range: 18 to 39 years) and the mean preoperative spherical equivalent (SEQ) was -4.68 ± 1.94 D (range: -0.96 to -9.50 D), with a mean astigmatism of -1.87 ± 1.33 D (range: 0.00 to -5.12 D). At the 12-month follow-up visit, visual acuity, SEQ, cylinder, safety index, and efficacy index were analyzed individually for each group. All lenticule extraction treatments were performed using the SmartSight method with the SCHWIND ATOS femtosecond laser.

RESULTS

Mean residual astigmatism was -0.04 ± 0.12 D (range: 0.00 to -0.50 D), -0.06 ± 0.12 D (range: 0.00 to -0.50 D), and -0.09 ± 0.15 (range: 0.00 to -0.50 D), for the low, moderate, and high astigmatism groups, respectively. Postoperative astigmatism within ±0.25 D was achieved in 99%, 96%, and 94%, for the low, moderate, and high astigmatism groups, respectively (P = .119). All eyes in each individual group were within ±0.50 D. The change in Snellen lines (comparing pre-operative CDVA to postoperative UDVA) showed a gain of one or more lines in 46% of the low astigmatism group, 63% of the moderate astigmatism group, and 32% of the high astigmatism group (P < .001).

CONCLUSIONS

The 12-month follow-up data show that SmartSight treatments for correction of myopia and myopic astigmatism with the SCHWIND ATOS is a safe, efficient, and accurate procedure irrespective of the level of preoperative astigmatism. However, a trend for refractive undercorrection was found for increasing astigmatism levels, partly reflected in the visual outcomes.

References

No references provided.

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties